Press releases | WebDisclosure

Basculer en Français

11180	Companies
247216	Keywords
175042	Articles
133524	Press releases

Home
Press releases

PRESS RELEASE

published on 03/26/2024 at 08:22, 2 years 6 months ago

Correction of a release from 25/03/2024, 17:30 CET/CEST - SURTECO GROUP SE: Preliminary result for the business year 2023
SURTECO GROUP SE reports preliminary results for the business year 2023, with consolidated net sales of €835.1 million and EBITDA of €66.6 million. Details on integration of Omnova divisions and future outlook shared

EBITDA Preliminary Results Business Year 2023 SURTECO GROUP SE Omnova Divisions
PRESS RELEASE

published on 03/26/2024 at 08:15, 2 years 6 months ago

EQS-Adhoc: AQUEDUCT EUROPEAN CLO 8 DESIGNATED ACTIVITY COMPANY: COMPANY ANNOUNCEMENT
AQUEDUCT EUROPEAN CLO 8 DESIGNATED ACTIVITY COMPANY announces changes to warehouse arrangements. Deed of Amendment signed on 20 March 2024

AQUEDUCT EUROPEAN CLO 8 Warehouse Facility Deed Deed Of Amendment Designated Activity Company Borrower
PRESS RELEASE

published on 03/26/2024 at 08:14, 2 years 6 months ago

MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024
MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024. The Group's diversified segments show varying performance in the 2023 financial year

Financial Performance 2024 Outlook Revenue Forecast EBITDA Margin MBB SE
PRESS RELEASE

published on 03/26/2024 at 08:01, 2 years 6 months ago

Original-Research: Surteco Group SE (von Sphene Capital GmbH): Buy
Sphene Capital GmbH bestätigt Kaufempfehlung fÜr Surteco Group SE mit unverändertem Kursziel von EUR 26,50. VorlÄufige Zahlen 2023 bestÄtigen Erwartungen. Prognose fÜr GeschÄftsjahr 2024 positiv

Kursziel Kaufempfehlung Sphene Capital GmbH SURTECO GROUP SE Jahreszahlen
PRESS RELEASE

published on 03/26/2024 at 08:00, 2 years 6 months ago

BIOSYNEX SA: AVALUN LAURÉATE DES TROPHÉES DE LA HEALTHTECH POUR LE DÉVELOPPEMENT DE SON NOUVEAU TEST DE MESURE RAPIDE DU FIBRINOGÈNE
AVALUN, filiale de BIOSYNEX, remporte le Trophée de la HealthTech pour son nouveau test de mesure rapide du fibrinogène. Le produit vise à améliorer les prises en charge d'urgence des hémorragies sévères

BIOSYNEX AVALUN Trophée De La HealthTech Test De Mesure Rapide Fibrinogène
PRESS RELEASE

published on 03/26/2024 at 08:00, 2 years 6 months ago

Cairn Homes Plc: Director/PDMR Shareholding
Cairn Homes Plc director, Michael Stanley, purchases 130,170 ordinary shares as part of bonus deferral obligations. Transaction details disclosed

Cairn Homes Plc Shareholding Transaction Disclosure Michael Stanley Bonus Deferral
PRESS RELEASE

published on 03/26/2024 at 08:00, 2 years 6 months ago

JOST closes fiscal year 2023 successfully and proposes a dividend of EUR 1.50 per share
JOST successfully closes fiscal year 2023, proposes EUR 1.50 dividend per share. Profitability rises with adjusted EBIT margin at 11.3%. Improved CO2 footprint noted

Financial Performance CO2 Emissions Dividend Proposal Fiscal Year 2023 JOST Werke SE
PRESS RELEASE

published on 03/26/2024 at 08:00, 2 years 6 months ago

Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc purchased 100,000 of its ordinary shares for cancellation as part of the share buyback program. Details of the transactions on Euronext Dublin and London Stock Exchange provided

London Stock Exchange Ordinary Shares Share Buyback Program Cairn Homes Plc Euronext Dublin
PRESS RELEASE

published on 03/26/2024 at 08:00, 2 years 6 months ago

Cairn Homes Plc: Holding(s) in Company
Cairn Homes Plc announces major shareholding notification with voting rights reaching 7.99% on 22/03/2024. Notification sent to Central Bank of Ireland

Voting Rights Cairn Homes Plc Notification Major Shareholding Central Bank Of Ireland
PRESS RELEASE

published on 03/26/2024 at 08:00, 2 years 6 months ago

DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE
Defence Therapeutics announces successful results for second-generation anti-cancer vaccine ARM-002TM, showing promising anti-tumoral response in melanoma model and plans for Phase I trial targeting solid tumors

Phase I Trial Defence Therapeutics Anti-cancer Vaccine ARM-002TM Melanoma

Accesswire

Published on 10/15/2026 at 14:05, 8 minutes ago

Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 14:00, 13 minutes ago

Tectonic Metals Drills 2.41 g/t Au over 59.44 metres, Including 11.82 g/t Au over 10.67 metres and 39.96 g/t Au over 3.05 metres at Alpha Bowl, Flat Gold Project, Alaska
Published on 10/15/2026 at 14:00, 13 minutes ago

Nine Mile Metals DDH WD-26-15 Intersects (2) VMS Zones Returning 4.88% Cu-Eq Over 7.6m and Acquires 14.42 km² of New Strategic Claims at Its Nine Mile Brook Project
Published on 10/15/2026 at 13:45, 28 minutes ago

Karbon-X (OTCQB:KARX) Secures €1.88 Million (US$2.18 Million) in Net Trading Margin Through New European Low-Carbon Fuel Contracts
Published on 10/15/2026 at 13:30, 43 minutes ago

Nextech3D.ai Unveils AI-Native Map D, Bringing Agentic AI to the Event Industry

View all ACCESSWIRE

EQS Group

Published on 10/15/2026 at 14:05, 8 minutes ago

Four Leading Institutions Complete Initial Clinical Experience with Spectrum Dynamics Medical's All-Energy Digital SPECT/CT
Published on 10/15/2026 at 14:05, 8 minutes ago

INNOVATE. COMPETE. WIN TOGETHER. From World Cup Jerseys to Circular Innovation, Far Eastern New Century Leads the Way in Sustainable Textiles
Published on 10/15/2026 at 14:05, 8 minutes ago

IGEL Appoints U.S. Zero Trust Leader Randy Resnick to Advance the IGEL Adaptive Secure Endpoint Platform™ Strategy
Published on 10/15/2026 at 14:00, 13 minutes ago

Mutares completes the acquisition of long-established Steinmüller Engineering GmbH from IHI Group
Published on 10/15/2026 at 13:43, 30 minutes ago

EQS-Adhoc: RC Industrie Immobilien SE: Acquisition of a fully let commercial and industrial property in Mittenwalde for EUR 2.375 million

Les Echos

Published on 10/15/2026 at 07:27, 6 hours 45 minutes ago

Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
Published on 10/15/2026 at 07:27, 6 hours 45 minutes ago

Saint-Gobain renforce son offre pour le marché des infrastructures en Amérique du Nord avec l’acquisition de D.S. Brown dans la chimie de la construction
Published on 10/14/2026 at 18:00, 20 hours 13 minutes ago

CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 20 hours 13 minutes ago

CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
Published on 10/14/2026 at 17:45, 20 hours 28 minutes ago

Mint : Résultats semestriels 2026.

View all LES ECHOS COMFI WIRE